Literature DB >> 20110092

Body image disturbance in 1000 male appearance and performance enhancing drug users.

Tom Hildebrandt1, Lauren Alfano, James W Langenbucher.   

Abstract

Body image disturbance (BID) among men has only recently become a phenomenon of clinical significance with noted heterogeneity in the behavioral consequences of these disturbances. The degree of heterogeneity among appearance and performance enhancing drug (APED) users is unknown and an empirically derived framework for studying BID is necessary. APED users (N=1000) were recruited via the Internet and they completed a comprehensive online assessment APED use patterns, motivations, consequences, and BID. Data were evaluated using latent trait, latent class, and factor mixture models. Model results were validated using a range of covariates including cycle characteristics, age, APED history, and APED risk. A 1-Factor, 4-Class model provided the best fit to the data with Class 1 scoring the highest on all measures of BID and Class 4 the lowest on all measures. Class 2 differed in their preference for being lean over muscular and Class 3 preferred adding mass and size. Each class was associated with unique risks, APED history, and training identity. Not all APED users suffer from significant BID and there are unique profiles for those with elevated BID. Future research on male BID should account for this structure in order to better define relevant diagnostic categories and evaluate the clinical significance of BID.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20110092      PMCID: PMC2889003          DOI: 10.1016/j.jpsychires.2010.01.001

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  32 in total

1.  Anabolic-androgenic steroid use disorders among a sample of Australian competitive and recreational users.

Authors:  J Copeland; R Peters; P Dillon
Journal:  Drug Alcohol Depend       Date:  2000-07-01       Impact factor: 4.492

2.  Investigating population heterogeneity with factor mixture models.

Authors:  Gitta H Lubke; Bengt Muthén
Journal:  Psychol Methods       Date:  2005-03

3.  The growing commercial value of the male body: a longitudinal survey of advertising in women's magazines.

Authors:  H G Pope; R Olivardia; J J Borowiecki; G H Cohane
Journal:  Psychother Psychosom       Date:  2001 Jul-Aug       Impact factor: 17.659

4.  Men, muscles, and body image: comparisons of competitive bodybuilders, weight trainers, and athletically active controls.

Authors:  T C Pickett; R J Lewis; T F Cash
Journal:  Br J Sports Med       Date:  2005-04       Impact factor: 13.800

5.  Muscle dysmorphia. An underrecognized form of body dysmorphic disorder.

Authors:  H G Pope; A J Gruber; P Choi; R Olivardia; K A Phillips
Journal:  Psychosomatics       Date:  1997 Nov-Dec       Impact factor: 2.386

Review 6.  Muscle dysmorphia: a critical review of the proposed criteria.

Authors:  B Chung
Journal:  Perspect Biol Med       Date:  2001       Impact factor: 1.416

7.  Anabolic steroid users' attitudes towards physicians.

Authors:  Harrison G Pope; Gen Kanayama; Martin Ionescu-Pioggia; James I Hudson
Journal:  Addiction       Date:  2004-09       Impact factor: 6.526

8.  Modeling population heterogeneity in appearance- and performance-enhancing drug (APED) use: applications of mixture modeling in 400 regular APED users.

Authors:  Thomas Hildebrandt; James W Langenbucher; Sasha J Carr; Pilar Sanjuan
Journal:  J Abnorm Psychol       Date:  2007-11

9.  Bigorexia: bodybuilding and muscle dysmorphia.

Authors:  Philip E Mosley
Journal:  Eur Eat Disord Rev       Date:  2009-05

10.  Sociocultural influences on adolescent boys' body image and body change strategies.

Authors:  Jacqueline N Stanford; Marita P McCabe
Journal:  Body Image       Date:  2005-06
View more
  24 in total

1.  Culture, psychosomatics and substance abuse: the example of body image drugs.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Psychother Psychosom       Date:  2012-01-18       Impact factor: 17.659

2.  The impact of gender on the assessment of body checking behavior.

Authors:  Lauren Alfano; Tom Hildebrandt; Katie Bannon; Catherine Walker; Kate E Walton
Journal:  Body Image       Date:  2010-11-18

3.  Development and validation of the appearance and performance enhancing drug use schedule.

Authors:  Tom Hildebrandt; James W Langenbucher; Justine Karmin Lai; Katharine L Loeb; Eric Hollander
Journal:  Addict Behav       Date:  2011-05-11       Impact factor: 3.913

4.  Concerns related to eating, weight, and shape: typologies and transitions in men during the college years.

Authors:  Angela S Cain; Amee J Epler; Douglas Steinley; Kenneth J Sher
Journal:  Int J Eat Disord       Date:  2011-07-08       Impact factor: 4.861

5.  The influence of age of onset and acute anabolic steroid exposure on cognitive performance, impulsivity, and aggression in men.

Authors:  Tom Hildebrandt; James W Langenbucher; Adrianne Flores; Seth Harty; Heather A Berlin; Heather Berlin
Journal:  Psychol Addict Behav       Date:  2014-05-19

Review 6.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

Review 7.  Anabolic androgenic steroid abuse in the United Kingdom: An update.

Authors:  Carrie Mullen; Benjamin J Whalley; Fabrizio Schifano; Julien S Baker
Journal:  Br J Pharmacol       Date:  2020-03-03       Impact factor: 8.739

8.  Performance-enhancing drugs on the web: a growing public-health issue.

Authors:  Brian P Brennan; Gen Kanayama; Harrison G Pope
Journal:  Am J Addict       Date:  2013-02-01

Review 9.  Illicit use of androgens and other hormones: recent advances.

Authors:  Gen Kanayama; Harrison G Pope
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-06       Impact factor: 3.243

10.  Psychosocial correlates of gap time to anabolic-androgenic steroid use.

Authors:  Patrycja Klimek; Tom Hildebrandt
Journal:  Int J Eat Disord       Date:  2018-03-15       Impact factor: 4.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.